Abiopharma

News list

(96% Positive) UNITED THERAPEUTICS CORPORATION (UTHR) Files Form 8-K

Full text

News bot March 9, 2026, 9:18 p.m.
📋 UNITED THERAPEUTICS CORPORATION (UTHR) - Other Event

Filing Date: 2026-03-09

Accepted: 2026-03-09 17:18:10

Event Type: Other Event

Event Details:

UNITED THERAPEUTICS CORPORATION (UTHR) Provides Business Update UNITED THERAPEUTICS CORPORATION (UTHR) issued a business update covering recent developments.
🔍 Detailed Event Analysis:
AI Summary: United Therapeutics Corporation (Nasdaq: UTHR) announced today that the company’s Board of Directors has authorized a new stock repurchase program of up to $2 billion over the next year. In addition, the company entered into ASR agreements with Citibank, N.A. (Citi) today to implement an initial $1.5 billion ASR program.
Key Elements Identified:
Drugs/Compounds: repurchases, Agreements, conviction
Diseases/Conditions: aggregate $1
Organizations: Accelerated Share Repurchase Program Agreements, Board of Directors, ASR
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval: Not available
- Executive Changes: Not available
Structured Data:
- Company Name: UNITED THERAPEUTICS CORPORATION
- Ticker Symbol: UTHR